Experimental study on healing of long bone defects treated with fibrin membrane enriched with platelet growth factors and periosteal mesenchymal stem cells in rabbit: radiographical and histopathological evaluations

Document Type: Original Article

Authors

1 Department of Clinical Sciences, Faculty of Veterinary Medicine, Ardakan University, Ardakan, Iran

2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Iran

3 Department of Hematology and Medical laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran

4 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran

Abstract

The present study was designed to evaluate the effects of platelet growth factors and periosteal mesenchymal stem cells on bone healing process, radiographically. Forty male White New Zealand rabbits in five equal groups were used in this study. A 2 mm full thickness bone defect was made in left radial bone of each animal. In group A (control) the defect was left with no medical intervention. In group B the defect was covered by a fibrin membrane. In group C the defect was covered by a fibrin membrane plus platelet growth factors. In group D the defect was covered by a fibrin membrane plus periosteal mesenchymalstem cells, and in group E the defect was covered by a fibrin membrane enriched with platelet growth factors and periosteal mesenchymalstem cells. Radiological evaluation was done immediately after surgery (week 0) and then at the 1st, 2nd, 4th, 6th and 8th weeks after operation. At the end of the eighth week, bone samples were taken to evaluate the histopathology. The radiological and histopathological observations showed a superior bone healing in the groups D and E, after eight weeks in comparison with the groups A, B and C. According to this study, it could be concluded that the platelet growth factors and periosteal mesenchymalstem cells could promote bone regeneration in long bone defects in a rabbit model.

Keywords

Main Subjects


 

  1. Buza JA, Einhorn T. Bone healing in 2016. Clin Cases Miner Bone Metab 2016; 13(2):101–105.
  2. Morshed S. Current options for determining fracture union. Adv Med. 2014; 2014:708574. doi: 10.1155/2014/708574.
  3. Bishop JA, Palanca AA, Bellino MJ, et al. Assessment of compromised fracture healing. J Am Acad Orthop Surg 2012; 20(5): 273-282.
  4. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005; 36(12): 1392-1404.
  5. Rose FR, Oreffo RO. Bone tissue engineering: Hope vs hype. Biochem Biophys Res Commun 2002;292(1):1-7.
  6. Laki K. Our ancient heritage in blood clotting and some of its consequences. Ann N Y Acad Sci 1972; 202(1): 297-307.
  7. Machlus KR, Thon JN, Italiano JE. Interpreting the developmental dance of the megakaryocyte: A review of the cellular and molecular processes mediating platelet formation. Br J Hematol 2014; 165(2): 227-236.
  8. Yip J, Shen Y, Berndt MC, et al. Primary platelet adhesion receptors. IUBMB Life 2005; 57(2):103-108.
  9. Cortese A, Pantaleo G, Borri A, et al. Platelet-rich fibrin (PRF) in implant dentistry in combination with new bone regenerative technique in elderly patients. Int J Surg Case Rep 2016; 28: 52-56.
  10. Kiran NK, Mukunda KS, Raj TNT. Platelet concentrates: A promising innovation in dentistry. J Dent Sci Res 2011; 2(1): 50-61.
  11. Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury 2007; 38(1): 11-25.
  12. Simpson A, Mills L, Noble B. The role of growth factors and related agents in accelerating fracture healing. J Bone Joint Surg Br 2006; 88(6): 701-705.
  13. Veillette CJ, McKee MD. Growth factors-BMPs, DBMs, and buffy coat products: Are there any proven differences amongst them? Injury 2007; 38(1): 38-48.
  14. Borie E, Olivi DG, Orsi IA, et al. Platelet-rich fibrin application in dentistry: A literature review. Int J Clin Exp Med 2015; 8(5): 7922-7929.
  15. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101(3): e45-50.
  16. Passaretti F, Tia M, Esposito VD, et al. Growth-promoting action and growth factor release by different platelet derivatives. Platelets 2014; 25(4): 252-256.
  17. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101(3): e37-44.
  18. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet rich fibrin (L-PRF). Trends Biotechnol 2009; 27(3): 158-167.
  19. Zhang Y, Tangl S, Huber CD, et al. Effects of Choukroun’s platelet-rich fibrin on bone regeneration in combination with deproteinized bovine bone mineral in maxillary sinus augmentation: A histological and histomorphometric study. J Craniomaxillofac Surg 2012; 40(4): 321-328.
  20. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001; 10(4): 225-228.
  21. Gupta V, Bains BK, Singh GP, et al. Regenerative potential of platelet rich fibrin in dentistry: Literature review. Asian J Oral Health Allied Sci 2011; 1(1): 22-28.
  22. Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generationplatelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101(3): e56-60.
  23. Li Q, Pan S, Dangaria SJ, et al. Platelet-rich fibrin promotes periodontal regeneration andenhances alveolar bone augmentation. Biomed Res Int 2013; 638043. doi: 10.1155/2013/638043.
  24. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101(3): e51-55.
  25. Saluja H, Dehane V, Mahindra U. Platelet-Rich fibrin: A second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg 2011; 1(1): 53-57.
  26. Kim TH, Kim SH, Sandor GK, et al. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol 2014; 59(5): 550-558.
  27. Cortese A, Pantaleo G, Borri A, et al. Platelet-rich fibrin (PRF) in implant dentistry in combination with new bone regenerative technique in elderly patients. Int J Surg Case Rep 2016; 28: 52-56.
  28. Ferretti C , Borsari V, Falconi M, et al. Human periosteum-derived stem cells for tissue engineering applications: The Role of VEGF. Stem Cell Rev 2012; 8(3): 882-890.
  29. Nakahara H, Bruder SP, Goldberg VM, et al. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res 1990; 259(10): 223-232.
  30. Emery SE, Brazinski MS, Koka A, et al. The biological and biomechanical effects of irradiation on anterior spinal bone grafts in a canine model. J Bone Joint Surg. 1994; 76: 540-548.
  31. Leow JM, Clement ND, Tawonsawatruk T, et al. The radiographic union scale in tibial (RUST) fractures. Bone Joint Res 2016; 5(4): 116-121.
  32. Oryan A, Meimandi Parizi A, Shafiei-Sarvestani Z, et al. Effects of combined hydroxyapatite and human platelet rich plasma on bone healing in rabbit model: Radiological, macroscopical, histopathological and biomechanical evaluation. Cell Tissue Bank 2012; 13: 639-651.
  33. Shafiei-Sarvestani Z, Oryan A, Sadegh Bigham A, et al. The effect of hydroxyapatite hPRP, and coral-hPRP on bone healing in rabbits: Radiological, biomechanical, macroscopic and histopathologic evaluation. Int J Surg 2012; 10: 96-101.
  34. Connolly JF, Shindell R. Percutaneous marrow injection for an ununited tibia. Nebr Med J 1986; 71(4): 105-107.
  35. Healey JH, Zimmerman PA, McDonnell JM, et al. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 1990; 256: 280-285.
  36. Bajada S, Harrison PE, Ashton BA, et al. Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. J Bone Joint Surg Br 2007; 89(10): 1382-1386.
  37. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplant ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1995; 5(3): 309-313.
  38. Del Corso M, Toffler M, Dohan Ehrenfest DM. Use of an autologous leukocyte and platelet-rich fibrin (L-PRF) membrane in post-avulsion sites: an overview of Choukroun’s PRF. J Implant Adv Clin Dent 2010; 1: 27-35.
  39. Cortese A, Pantaleo G, Amato M, et al. Chin Wing osteotomy for bilateral Goldenhar syndrome treated by chin wing mentoplasty: Aesthetic, functional, and histological considerations. J Craniofac Surg 2015; 26(5): 1628-1630.
  40. Schwartz-Arad D, Levin L, Sigal L. Surgical success of intraoral autogenous block onlay bone grafting for alveolar ridge augmentation .Implant Dent 2005; 14(2): 131-138.
  41. Lee HJ, Choi BH, Jung JH, et al. Maxillary sinus floor augmentation using autogenous bone grafts and platelet-enriched fibrin glue with simultaneous implant placement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(3): e329-333.
  42. Migdalska A, Molineux G, Demuynck H, et al. Growth inhibitory effects of transforming growth factor-β1 in vivo. Growth Factors 1991; 4(3): 239-245.
  43. Jensen TB, Rahbek O, Overgaard S. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J Orthop Res 2004; 22(3): 653-658.